about
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a ...
Read More
9.79
0.03
(0.31%)
680.6K
XNAS Volume
XNAS 30 Dec, 2025 1:56 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Replimune Grp Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..